Ledger.Open graph →
SEC Form D · filed November 29, 2017

Chase Therapeutics Corp

Offering
$1.3M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WASHINGTON, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Thomas N. Chase · Washington, Washington, D.C.Exec · DirectorRichard P. Dulik · Washington, Washington, D.C.ExecKathleen N. Clarence-Smith · Washington, Washington, D.C.DirectorVaibhav Kumar · NEW YORK, NYExecJames D. Lanshe · Lakeway, TXExec · DirectorKathleen N. Clarence-Smith · Washington, Washington, D.C.DirectorPantas Sutardja · Campbell, CAExec · DirectorShawn Horwitz · Woodland Hills, CAExecVasily Andreev · Pacifica, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗